Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
... which has previously
achieved successful phase II results in patients with cat
is one of the leading causes of allergic reactions in No...h technology. We have already
achieved encouraging results in patients with cat
allergies, and are excited
to be extending our portfolio of therapies to en...
One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
...- in the United States, Canada, and abroad -- have had an impact on everything from health care (the pacemaker from the University of Minnesota , the cat
scan from Georgetown, laser cataract surgery from the University of California-Los Angeles ) to better living at home (plexiglass from McGill Univer...
Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
...t study, which is underway in Canada, will enrol 48 patients
with confirmed cat
allergies and cat-allergen induced asthma. The randomised,
double-blind, pl...current treatments is approximately $12
billion per year. The prevalence of cat
allergies is also high, with 1-in-6
Americans and nearly 10% of Europeans s...
Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
...cruitment for a further phase II clinical trial in cat
study, which is underway in Canada, h...t of the ongoing study, each patient is
exposed to cat
allergens in a controlled environmental exposure c...roximately
$12 billion per year. The prevalence of cat
allergies is high, with 1-in-6
Americans and nearl...
Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
...dy of its
ToleroMune(R) technology in the field of cat
allergy. The trial builds on
positive results achi...nts experienced
substantially reduced reactions to cat
allergens after a single
administration of ToleroM... study, patients will receive a controlled
dose of cat
allergen in an environmental exposure chamber both...
Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
...allergy technology, ToleroMune(R), in the field of cat
The trial showed that ToleroMune treatmen...llergic reactions to the allergen that causes most cat
importantly was well tolerated by a...ermany, where patients
with a confirmed history of cat
allergies received a single dose of
Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
...the most sensitive and specific
diagnostic modality for the prostate evaluation in the world, replacing
substandard scanning procedures like PET scan, cat
scan and Prostascint
scans. The MRI -S at 3.0 Tesla allows imaging of the entire prostate,
thereby, creating a roadmap; thereby, allowing selective ta...
Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
...million in loan-based
project financing to accelerate the development of Dynavax's allergy
franchise, including TOLAMBA and the preclinical peanut and cat
programs. Repayment of a portion of the loans for TOLAMBA is contingent
upon the positive outcome of the chamber study. If the TOLAMBA program...
One Shot of Gene Therapy Spreads Through Brain in Animal Study
...rage disease, called alpha-
mannosidosis, in cats. In that study, a treated cat
improvement in walking, compared to an untreated cat
with the disease. If the animal results can be successfully extrapolated t...